Keros Therapeutics, Inc. (KROS)

NASDAQ: KROS · Real-Time Price · USD

11.38

-0.27 (-2.32%)

At close: Jul 8, 2026, 4:00 PM EDT

11.44

+0.06 (0.53%)

After-hours: Jul 8, 2026, 5:00 PM EDT

Keros Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	281.5	287.42	559.93	331.15	279.05	230.04
Cash & Short-Term Investments	281.5	287.42	559.93	331.15	279.05	230.04
Cash Growth	-60.93%	-48.67%	69.09%	18.67%	21.30%	-13.48%
Accounts Receivable	0.4	3.57	2.74	0.14	-	18
Other Receivables	2.25	2.25	-	-	-	-
Total Trade Receivables	2.65	5.82	2.74	0.14	-	18
Other Current Assets	6.53	22.2	26.22	16	6.72	3.4
Total Current Assets	290.68	315.43	588.89	347.29	285.77	251.44
Net Property, Plant & Equipment	20.17	21.14	23.49	19.47	17.57	2.4
Other Long-Term Assets	1.45	1.45	3.51	3.26	3.45	1.41
Total Assets	312.29	338.02	615.89	370.03	306.78	255.25
Accounts Payable	1.49	1.97	4.6	5.45	3.34	3.65
Accrued Expenses	8.86	16.04	20.87	17.92	12.75	7.34
Current Portion of Leases	2.5	2.41	1.98	1.01	0.46	0.86
Total Current Liabilities	12.85	20.41	27.45	24.37	16.55	11.85
Long-Term Leases	13.81	14.48	16.88	13.44	12.81	0.23
Total Long-Term Liabilities	13.81	14.48	16.88	13.44	12.81	0.23
Total Liabilities	26.66	34.89	44.33	37.81	29.36	12.08
Common Stock	0	0	0	0	0	0
Treasury Stock	-384.56	-384.56	-	-	-	-
Additional Paid-in Capital	1,176	1,169	1,140	713.64	505.86	366.93
Retained Earnings	-505.47	-481.77	-568.78	-381.43	-228.43	-123.76
Shareholders' Equity	285.63	303.13	571.55	332.21	277.42	243.17
Total Liabilities & Equity	312.29	338.02	615.89	370.03	306.78	255.25
Total Debt	16.31	16.88	18.86	14.44	13.27	1.09
Net Cash (Debt)	265.19	270.53	541.07	316.7	265.78	228.95
Net Cash Growth	-1.98%	-50.00%	70.84%	19.16%	16.09%	-13.60%
Net Cash Per Share	8.28	7.15	14.45	10.76	10.53	9.81
Book Value	285.63	303.13	571.55	332.21	277.42	243.17
Book Value Per Share	8.92	8.01	15.27	11.28	10.99	10.42
Tangible Book Value	285.63	303.13	571.55	332.21	277.42	243.17
Tangible Book Value Per Share	8.92	8.01	15.27	11.28	10.99	10.42

SEC Filings: 10-K · 10-Q